Y Intercept Hong Kong Ltd increased its stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 577.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,107 shares of the insurance provider’s stock after purchasing an additional 58,048 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Allstate were worth $13,711,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the company. Arlington Trust Co LLC grew its stake in Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 89 shares during the period. Hughes Financial Services LLC bought a new stake in Allstate in the 1st quarter valued at $28,000. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Allstate by 315.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after purchasing an additional 126 shares in the last quarter. Hilltop National Bank bought a new stake in Allstate in the 2nd quarter valued at approximately $34,000. Finally, Meeder Asset Management Inc. lifted its stake in Allstate by 113.8% in the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 99 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.
Allstate Stock Performance
Shares of ALL opened at $193.37 on Monday. The stock has a 50 day moving average of $204.27 and a 200 day moving average of $201.14. The company has a market capitalization of $50.95 billion, a price-to-earnings ratio of 9.09, a PEG ratio of 0.70 and a beta of 0.38. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37.
Analysts Set New Price Targets
ALL has been the topic of a number of analyst reports. Jefferies Financial Group increased their price target on Allstate from $254.00 to $255.00 and gave the stock a “buy” rating in a research report on Monday, August 11th. Barclays reaffirmed an “underweight” rating and issued a $198.00 price objective (up from $188.00) on shares of Allstate in a research note on Thursday, July 31st. BMO Capital Markets lifted their target price on Allstate from $230.00 to $235.00 and gave the stock an “outperform” rating in a report on Wednesday, August 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Allstate in a research report on Friday. Finally, Citigroup upgraded Allstate to a “hold” rating in a report on Wednesday, August 13th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $234.27.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- Find and Profitably Trade Stocks at 52-Week Lows
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What is a Special Dividend?
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Upcoming IPO Stock Lockup Period, Explained
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
